| . | A-FMR group (n = 56) . | V-FMR group (n = 79) . | P-value . |
|---|---|---|---|
| Clinical characteristics | |||
| Age, years | 77 ± 10 | 75 ± 10 | 0.112 |
| Female sex (%) | 32 (57) | 25 (32) | 0.003 |
| Body surface area, m2 | 1.84 ± 0.26 | 1.90 ± 0.24 | 0.180 |
| Duration of AF/AFL, years | 6.4 ± 6.8 | 7.9 ± 8.5 | 0.392 |
| Systolic BP, mmHg | 125 ± 17 | 115 ± 16 | 0.001 |
| Diastolic BP, mmHg | 73 ± 13 | 73 ± 12 | 0.831 |
| Heart rate, bpm | 83 ± 18 | 81 ± 19 | 0.872 |
| NYHA functional class III or IV (%) | 39 (70) | 68 (86) | 0.020 |
| Coronary artery disease (%) | 17 (30) | 43 (54) | 0.006 |
| Lead insertion in RV (%) | 16 (29) | 32 (41) | 0.153 |
| Hypertension (%) | 47 (84) | 65 (82) | 0.802 |
| Diabetes mellitus (%) | 13 (23) | 19 (24) | 0.910 |
| COPD (%) | 11 (20) | 7 (9) | 0.069 |
| Laboratory data | |||
| BNP level, pg/mL | 501 ± 457 | 1136 ± 1159 | 0.001 |
| Serum creatinine level, mg/dL | 1.4 ± 0.9 | 1.8 ± 1.4 | 0.067 |
| . | A-FMR group (n = 56) . | V-FMR group (n = 79) . | P-value . |
|---|---|---|---|
| Clinical characteristics | |||
| Age, years | 77 ± 10 | 75 ± 10 | 0.112 |
| Female sex (%) | 32 (57) | 25 (32) | 0.003 |
| Body surface area, m2 | 1.84 ± 0.26 | 1.90 ± 0.24 | 0.180 |
| Duration of AF/AFL, years | 6.4 ± 6.8 | 7.9 ± 8.5 | 0.392 |
| Systolic BP, mmHg | 125 ± 17 | 115 ± 16 | 0.001 |
| Diastolic BP, mmHg | 73 ± 13 | 73 ± 12 | 0.831 |
| Heart rate, bpm | 83 ± 18 | 81 ± 19 | 0.872 |
| NYHA functional class III or IV (%) | 39 (70) | 68 (86) | 0.020 |
| Coronary artery disease (%) | 17 (30) | 43 (54) | 0.006 |
| Lead insertion in RV (%) | 16 (29) | 32 (41) | 0.153 |
| Hypertension (%) | 47 (84) | 65 (82) | 0.802 |
| Diabetes mellitus (%) | 13 (23) | 19 (24) | 0.910 |
| COPD (%) | 11 (20) | 7 (9) | 0.069 |
| Laboratory data | |||
| BNP level, pg/mL | 501 ± 457 | 1136 ± 1159 | 0.001 |
| Serum creatinine level, mg/dL | 1.4 ± 0.9 | 1.8 ± 1.4 | 0.067 |
Data are presented as mean ± standard deviation or n (%).
AF, atrial fibrillation; AFL, atrial flutter; A-FMR, atrial functional mitral regurgitation; BNP, B-type natriuretic peptide; BP, blood pressure; COPD, chronic obstructive pulmonary disease; NYHA, New York Heart Association; RV, right ventricle; V-FMR, ventricular functional mitral regurgitation.
| . | A-FMR group (n = 56) . | V-FMR group (n = 79) . | P-value . |
|---|---|---|---|
| Clinical characteristics | |||
| Age, years | 77 ± 10 | 75 ± 10 | 0.112 |
| Female sex (%) | 32 (57) | 25 (32) | 0.003 |
| Body surface area, m2 | 1.84 ± 0.26 | 1.90 ± 0.24 | 0.180 |
| Duration of AF/AFL, years | 6.4 ± 6.8 | 7.9 ± 8.5 | 0.392 |
| Systolic BP, mmHg | 125 ± 17 | 115 ± 16 | 0.001 |
| Diastolic BP, mmHg | 73 ± 13 | 73 ± 12 | 0.831 |
| Heart rate, bpm | 83 ± 18 | 81 ± 19 | 0.872 |
| NYHA functional class III or IV (%) | 39 (70) | 68 (86) | 0.020 |
| Coronary artery disease (%) | 17 (30) | 43 (54) | 0.006 |
| Lead insertion in RV (%) | 16 (29) | 32 (41) | 0.153 |
| Hypertension (%) | 47 (84) | 65 (82) | 0.802 |
| Diabetes mellitus (%) | 13 (23) | 19 (24) | 0.910 |
| COPD (%) | 11 (20) | 7 (9) | 0.069 |
| Laboratory data | |||
| BNP level, pg/mL | 501 ± 457 | 1136 ± 1159 | 0.001 |
| Serum creatinine level, mg/dL | 1.4 ± 0.9 | 1.8 ± 1.4 | 0.067 |
| . | A-FMR group (n = 56) . | V-FMR group (n = 79) . | P-value . |
|---|---|---|---|
| Clinical characteristics | |||
| Age, years | 77 ± 10 | 75 ± 10 | 0.112 |
| Female sex (%) | 32 (57) | 25 (32) | 0.003 |
| Body surface area, m2 | 1.84 ± 0.26 | 1.90 ± 0.24 | 0.180 |
| Duration of AF/AFL, years | 6.4 ± 6.8 | 7.9 ± 8.5 | 0.392 |
| Systolic BP, mmHg | 125 ± 17 | 115 ± 16 | 0.001 |
| Diastolic BP, mmHg | 73 ± 13 | 73 ± 12 | 0.831 |
| Heart rate, bpm | 83 ± 18 | 81 ± 19 | 0.872 |
| NYHA functional class III or IV (%) | 39 (70) | 68 (86) | 0.020 |
| Coronary artery disease (%) | 17 (30) | 43 (54) | 0.006 |
| Lead insertion in RV (%) | 16 (29) | 32 (41) | 0.153 |
| Hypertension (%) | 47 (84) | 65 (82) | 0.802 |
| Diabetes mellitus (%) | 13 (23) | 19 (24) | 0.910 |
| COPD (%) | 11 (20) | 7 (9) | 0.069 |
| Laboratory data | |||
| BNP level, pg/mL | 501 ± 457 | 1136 ± 1159 | 0.001 |
| Serum creatinine level, mg/dL | 1.4 ± 0.9 | 1.8 ± 1.4 | 0.067 |
Data are presented as mean ± standard deviation or n (%).
AF, atrial fibrillation; AFL, atrial flutter; A-FMR, atrial functional mitral regurgitation; BNP, B-type natriuretic peptide; BP, blood pressure; COPD, chronic obstructive pulmonary disease; NYHA, New York Heart Association; RV, right ventricle; V-FMR, ventricular functional mitral regurgitation.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
